Table 6 Logistic regression model results for differentiating the ≥ 50% response rate
From: Real-life experiences with galcanezumab and predictors for treatment response in Turkey
Variables | B | SE | Wald | Df | Sig | OR | 95% C.I. Lower-upper | |
|---|---|---|---|---|---|---|---|---|
Gender | -0.453 | 0.332 | 1.860 | 1 | 0.173 | 0.636 | 0.331 | 1.219 |
≥ 3 previous preventives | 0.925 | 0.275 | 11.273 | 1 | 0.01 | 2.521 | 1.470 | 4.326 |
Ictal nausea | -0.514 | 0.313 | 2.703 | 1 | 0.100 | 0.598 | 0.324 | 1.104 |
Constant | 1.604 | 0.212 | 57.085 | 1 | 0.000 | 4.971 | ||